Neural pathology quantification links enlarged brain spaces to vascular amyloid
Source check: Source checked. Not independent scientific confirmation.
Finding: Convolutional models quantified vascular amyloid and related pathology in donated brain tissue. In 19 cerebral-amyloid-angiopathy cases, enlarged perivascular spaces were associated with amyloid burden in overlying vessels after accounting for other pathology. Paired MRI and histology supported anatomical interpretation. Cross-sectional autopsy findings do not establish impaired clearance as the cause or the sequence of changes.
Technology: Aiforia convolutional neural networks; three-dimensional U-Net; SmartInterpol
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Validated CNNs quantify vascular amyloid/fibrin pathology, while learned high-resolution MRI segmentation supports regional anatomical analysis.
- Test and result
- Cross-sectional autopsy tissue quantification, regional MRI/histology comparisons and mixed-effects association analysis in 19 amyloid-angiopathy cases.
- Limitation / still unknown
- Causal direction, clearance dynamics and population generalizability remain unestablished; the selected donation cohort was small and automated in-vivo MRI segmentation was not reliable.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC9047512/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Primary relevant model Methods, Results and limitations; exact primary identity and current primary PubMed correction/retraction relationships checked..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.